Anderson, SCNCT07496450Now EnrollingIRB Ready

Influenza Clinical Trial in Anderson, SC

Access cutting-edge influenza treatment through this clinical trial at a research site in Anderson. Study-provided care at no cost to qualified participants.

Sponsored by ModernaTX, Inc.

Quick Self-Assessment

See if you qualify for this Anderson location

Preparing your pre-screening questions…

Expert Care in Anderson

Access influenza specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related influenza treatment provided free

Apply for This Anderson Location

Check if you qualify for this influenza clinical trial in Anderson, SC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Anderson

    Convenient for SC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Anderson site if eligible
  4. 4Begin participation

About This Influenza Study in Anderson

The purpose of this study is to evaluate humoral immunogenicity after 2 doses of mRNA-1018-H5, and to evaluate the safety and reactogenicity of mRNA-1018-H5 in adults ≥18 years of age.

Sponsor: ModernaTX, Inc.

Who Can Participate

Inclusion Criteria

Healthy as determined by medical evaluation including medical history; and physical examination. Participants with clinically stable chronic medical conditions are permitted.
Participants who are assigned female at birth or could become pregnant are eligible to participate if the participant is not pregnant or breast/chest feeding, and one of the following conditions applies:
Is a person of nonchildbearing potential (PONCBP) OR
Is a person of childbearing potential (POCBP)
A POCBP must have a negative highly sensitive pregnancy test at Screening and on the day of the first dose of study intervention. Key

Exclusion Criteria

Participant is acutely ill or febrile (body temperature ≥ 38.0 degrees Celsius \[°C\]/100.4 degrees Fahrenheit \[°F\]) within 72 hours prior to or at the Screening Visit or Day 1.
History of myocarditis, pericarditis, or myopericarditis.
History of Guillain-Barre syndrome.
Reported history of congenital or acquired immunodeficiency, immunosuppressive condition, asplenia, or recurrent severe infections disease.
Treated with antiviral therapies for influenza (eg, Tamiflu, Xofluza) within 28 days prior to Day 1.
Prior receipt of a pandemic influenza vaccine or participation in any pandemic influenza vaccine clinical study, including the mRNA-1018-P101 study.
Any medical, psychiatric, or occupational condition, that, in the opinion of the Investigator, might pose additional risk due to participation in the study or could interfere with adherence to study procedures or the interpretation of study results.
Participant has received systemic immunosuppressants including long-acting biological therapies that affect immune responses (eg, infliximab, methotrexate, omalizumab, etc.), within 180 days prior to Screening or plans to do so at any time during participation in the study.
Participant has received corticosteroids at ≥10 mg/day of prednisone or equivalent for \>14 days in total within 90 days prior to Day 1 (Baseline) or is anticipating the need for corticosteroids at any time during the study.
Participants has received any licensed vaccine authorized or approved by local health agency including mRNA vaccine ≤28 days prior to study intervention (Day 1) or plans to receive a vaccine authorized or approved by local health agency within 21 days after the study intervention.
Participant has participated in an interventional clinical study within 90 days prior to the Screening visit based on the medical history interview or plans to do so while participating in this study. Note: Other inclusion/exclusion criteria may apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Anderson?

Yes, this clinical trial (NCT07496450) has an active research site in Anderson, SC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Influenza Treatment Options in Anderson, SC

If you're searching for influenza treatment options in Anderson, SC, this clinical trial (NCT07496450) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Anderson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced influenza specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all influenza clinical trials near you to find additional studies recruiting in your area.

More Follicular Lymphoma Trials in Anderson, SC

See all follicular lymphoma clinical trials recruiting in Anderson — not just this study.

Browse Follicular Lymphoma Trials in Anderson →

Browse More Trials by Condition

Follicular Lymphoma TrialsInfluenza TrialsAll Conditions →

Ready to Join in Anderson?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Anderson, SC